MMR-proficient breast carcinoma groups (pMMR LS-BC and NC-BC) revealed comparable patterns, which often deviated from the dMMR LS-BC mutational pattern, implying the effect of MMR proficiency/deficiency (Figure 1A and 1B). This evidence concerns the gene MRC1 and breast cancer.